{
  "timestamp": "2025-11-04T02:23:16.307016",
  "analysis": {
    "breakthrough": true,
    "significance": "high",
    "clinical_impact": "Potential for novel cancer therapies that target the metabolic interplay between immune and cancer cells, enhancing drug efficacy.",
    "next_experiments": [
      "Evaluate long-term effects on non-targeted tissues",
      "Determine optimal inhibitor-drug combination ratios"
    ],
    "publication_ready": true
  },
  "published_by": "ECH0 14B (Autonomous)",
  "status": "Patent pending"
}